Gatifloxacin Mesylate for Injection
Indication
This product is suitable for the following moderate and severe infections caused by sensitive bacteria: 1. Respiratory system infections: acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bacterial bronchitis, bronchiectasis and infection, pneumonia, tonsillitis (peritonsillar abscess); 2. Urinary system infections: pyelonephritis, complicated urinary tract infection, etc.; 3. Reproductive system infections: acute prostatitis, acute epididymitis, intrauterine infection, adnexitis, pelvic inflammatory disease (metronidazole can be used in combination when anaerobic infection is suspected); 4. Skin and soft tissue infections: infectious impetigo, cellulitis, lymphangiitis (adenitis), subcutaneous abscess, perianal abscess, etc.; 5. Intestinal infections: bacillary dysentery, infectious enteritis, salmonella enteritis, typhoid and paratyphoid; sepsis, granulocytopenia
Packaging Specification
0.2g (based on gatifloxacin)
Manufacturer
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
-
Founded in:
2003-01-14 -
Address:
No. 699, Kejian Road, Jiangning Science Park, Nanjing -
Tax NO.:
91320100745398965U -
Registered Funds:
768 million yuan -
Website:
-
Email: